Klow vs TB-500 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Klow is a vendor peptide blend combining TB-500, BPC-157, KPV, and GHK-Cu - four compounds covering systemic tissue repair, angiogenesis, gut protection, anti-inflammation, and skin regeneration. It is the expanded version of Tri-Heal (TB-500 + BPC-157 + KPV), with GHK-Cu added f...
Calculate Klow dose →TB-500 is a synthetic fragment of Thymosin Beta-4, concentrated naturally in platelets and wound fluid. It promotes cell migration, angiogenesis, and systemic tissue repair via actin polymerization. Half-life of approximately 5 days enables twice-weekly dosing. WADA prohibited un...
Calculate TB-500 dose →| Parameter | Klow | TB-500 |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Vendor Blend | Extensively Studied |
| Half-Life | - | ~5 days |
| Typical Dose | - | 2.5–5 mg |
| Frequency | - | 2–3× per week |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.